The Impact of Smoking on Acute Ischemic Stroke

Similar documents
Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

How would you manage Ms. Gold

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Supplementary Online Content

Risk Factors for Ischemic Stroke: Electrocardiographic Findings

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Frequency of Cardiac Risk Factors in. Ischemic

Original Research Article

PFO Management update

Supplementary Online Content

C-Reactive Protein and Your Heart

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD


Stroke is the third-leading cause of death and a major

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

The presenter does not have any potential conflicts of interest to disclose

Thrombolysis in ischaemic stroke in rural North East Thailand by neurologist and non-neurologists

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Acute Medical Management. Bogachan Sahin, M.D., Ph.D. Department of Neurology

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Statins in lung disease

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Title:Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke

A trial fibrillation (AF) is a common arrhythmia that is

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk

Open Access The Addition of MRI to CT Based Stroke and TIA Evaluation Does Not Impact One year Outcomes

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Patient characteristics Intervention Comparison Length of followup

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

In cerebral infarction, the prognostic value of angiographic

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Risk Factors for Heart Disease

GENDER DISTRIBUTION OF RISK FACTORS IN ISCHEMIC STROKE IN HOSPITAL OF PSYCHIATRY AND NEUROLOGY FROM BRAŞOV

Arteriosclerosis & Atherosclerosis

Intima-Media Thickness

The Author(s) This article is published with open access by ASEAN Federation of Cardiology

CVD Prevention, Who to Consider

Stroke/TIA. Tom Bedwell

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Data Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.

Retrospective Study on the Safety and Efficacy of Clopidogrel in the Treatment of Acute Cerebral Infarction

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

DUKECATHR Dataset Dictionary

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Clinical Study Circle of Willis Variants: Fetal PCA

Statistical Fact Sheet Populations

Get With the Guidelines Stroke PMT. Quality Measure Descriptions

Ischemic Stroke in Critically Ill Patients with Malignancy

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Cerebrovascular Risk Factors and Clinical Classification of Strokes

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

Introduction. Risk factors of PVD 5/8/2017

Critical Review Form Therapy

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Nicolas Bianchi M.D. May 15th, 2012

1. Which one of the following patients does not need to be screened for hyperlipidemia:

Sex Differences in Stroke Risk and Quality of Life after Stroke

David Ramenofsky, MD Bryan Kestenbaum, MD

Early Hospitalization of Patients with TIA: A Prospective, Population-based Study

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

CVD risk assessment using risk scores in primary and secondary prevention

Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Coronary artery disease (CAD) risk factors

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Statin pretreatment and presentation patterns in patients with acute coronary syndromes

Pharmaceutical Help to Control Cholesterol

Mohammad Zubaid, MB, ChB, FRCPC, FACC

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Cryptogenic Strokes: Evaluation and Management

4. Which survey program does your facility use to get your program designated by the state?

The Muscatine Study Heart Health Survey

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Supplementary Online Content

CEREBRO VASCULAR ACCIDENTS

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Stroke/Carotid Artery Disease Outcome Detail (Form 121/132, CaD ppts)

EXAMINATION OF OxLDL SERUM LEVEL AS THE PROGNOSIS OF ACUTE THROMBOTIC ISCHEMIC STROKE

Mandana Nikpour 1,2, Murray B Urowitz 1*, Dominique Ibanez 1, Paula J Harvey 3 and Dafna D Gladman 1. Abstract

2018 Early Management of Acute Ischemic Stroke Guidelines Update

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

JAMA. 2011;305(24): Nora A. Kalagi, MSc

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Stroke/Carotid Artery Disease Outcome Detail (Form 121/132)

Each year, more than Americans have a stroke

EXS 145 Guidelines for Exercise Testing & Prescription

The TNT Trial Is It Time to Shift Our Goals in Clinical

Diabetes Mellitus: A Cardiovascular Disease

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

Transcription:

Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease Lung cancer COPD Independent major risk factor for CAD, cerebrovascular disease, and total atherosclerotic cardiovascular disease Pathogenesis of atherosclerosis Smoking and atherosclerosis Adverse effect on serum lipids ( LDL / TG and HDL) Damage the vascular wall Contribute to the inflammatory response ( CRP and Fibrinogen) Elevation in serum homocysteine Free radical-mediated oxidative stress The Atherosclerosis Risk in Communities (ARIC) Study. JAMA, 1998 10,914 subjects, progression of intimal-medial thickness of the carotid artery as assessed by ultrasound N: nonsmoker P: past smoker C: current smoker -E: without exposure to enviornmental smoke +E: with exposure to environmental smoke Cerebrovascular disease Cigarette smoking as a risk factor for stroke: the Frammingham study, JAMA, 1988;259:1025 1029 Cigarette smoking and risk of stroke in the Chinese adult population, stroke, 2008;39:1688-1693. Positive and dose-responsive relationship between smoking and risk of stroke Risk of recurrent stroke? RR of incidence RR of mortality Male 1.28 1.13 Female 1.25 1.19

Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke, stroke, 2010;41:487-493. Prognostic effect The smoking thrombolysis paradox and acute ischemic stroke, Neurology 2005;65:293 295 After adjusting for covariates, recent smokers who received thrombolysis had a significantly greater drop in 24-hour median stroke severity scores from baseline than nonsmokers who received thrombolysis and lower mortality over 1 year. Smoker nonsmoker p value ΔNIHSS at 24 hours 4.9 2.1 0.001 Survival rate at 1 year 82.0% 73.2% 0.031 Improved outcome after atherosclerotic stroke in male smoker, Journal of the Neurological Sciences 260 (2007) 43 48 Effect of Smoking Status on Outcome after Acute Ischemic Stroke, Cerebrovascular Disease 2006;21:260 265 Limitations Baseline variables? Functional status before acute stroke? First-ever or recurrent stroke? Duration of follow-up Smoking status after acute stroke? Questions What is the immediate impact of smoking on acute ischemic stroke? Is there any difference of prognostic effect between first-ever and recurrent stroke?

Patients Stroke Registry in Chang Gung Healthcare System (SRICHS) Total number of patients in 2009: 4274 Lacking on either admission or discharge Length of hospital stay within 30 days Total number of patients in study: 2901 Demographics, vascular risk factors, lab findings, NIHSS, medical complications, and length of acute ward stay Definition: Methods Smokers: any history of smoking before admission Recurrent stroke: information from patients or medical records ΔNIHSS= NIHSS score on admission discharge Severe neurological deficit: NIHSS 6 Favorable recovery: ΔNIHSS > 0 Statistics: SPSS 12.0 for Windows χ2 test for categorical variables Independent sample t test for continuous variables Multivariate logistic regression analysis Significance: p<0.05 Baseline data Nonsmokers (n=2009) Smokers (n=892) p value Results Age 69.3±12.3 63.9±12.7 <0.001 Male 959 (47.7%) 856(96.0%) <0.001 Risk factors Hypertension 1398(69.6%) 552(61.9%) <0.001 DM 699(34.8%) 248(27.8%) 0.121 Hyperlipidemia 426(21.3%) 188(21.2%) 0.934 Previous stroke 565(28.1%) 247(27.7%) 0.811 Previous TIA 78(3.9%) 34(3.8%) 0.927 Ischemic heart disease 164(8.2%) 81(9.1%) 0.412 VHD 19(0.9%) 6(0.7%) 0.463 Af 147(7.3%) 53(5.9%) 0.177 CHF 34(1.7%) 20(2.2%) 0.312 Baseline data Nonsmokers (n=2009) Smokers (n=892) p value Lab Fever 83(4.1%) 30(3.4%) 0.324 SBP 145.7±31.2 146.0±29.6 0.835 DBP 81.7±17.3 83.7±16.8 0.004 Anemia 589(29.3%) 191(21.4%) <0.001 Old lesion on brain CT 933(46.6%) 400(44.8%) 0.425 Stroke mechanism 0.013 Small vessel 893(44.4%) 412(46.2%) Large vessel 237(11.8%) 128(14.3%) Cardioembolism 320(15.9%) 114(12.8%) Other determined etiology 20(1.0%) 17(1.9%) Undetermined etiology 539(26.8%) 221(24.8%) Severity on admission NIHSS 5.8±7.0 4.6±5.0 <0.001 Course and Outcome Nonsmokers (n=2009) Smokers (n=892) p value Status upon discharge NIHSS 5.1±7.7 3.7±5.4 <0.001 BI 71.8±32.8 78.9±29.2 <0.001 mrs 2.7±1.9 2.4±1.9 <0.001 Neurological change ΔNIHSS 0.7±5.2 0.9±4.1 0.355 Functional change ΔBI 8.0±22.6 7.3±21.3 0.438 ΔmRS 0.4±1.6 0.5±1.6 0.637 Pneumonia 111(5.5%) 33(3.7%) 0.037 Acute ward stay (days) 9.4±6.3 9.1±5.8 0.151

Severe neurological deficit on admission NIHSS 6 on admission OR (95% CI) p value Age 1.021 (1.014-1.029) <0.001 Male 0.756 (0.625-0.915) 0.004 Af 1.673 (1.232-1.272) 0.001 Previous stroke 1.814 (0.443-0.668) <0.001 Previous TIA 0.493(1.479-2.226) 0.006 Dyslipidemia 0.631 (0.508-0.784) <0.001 Old lesion on brain CT 1.599 (1.326-1.928) <0.001 Smoking 1.053 (0.856-1.295) 0.624 Change of neurological deficit ΔNIHSS> 0 OR (95% CI) p value First ever stroke Pneumonia 0.331 (0.187-0.585) <0.001 NIHSS on admission 1.145 (1.118-1.172) <0.001 Smoking 0.990 (0.791-1.238) 0.928 Recurrent stroke Pneumonia 0.295(0.156-0.559) <0.001 Dyslipidemia 0.531 (0.388-0.727) <0.001 NIHSS on admission 1.061 (1.035-1.089) <0.001 TOAST classification 1.107 (1.009-1.214) 0.032 Smoking 1.055 (0.742-1.499) 0.766 Favorable baseline characteristics Characteristics of smoker with acute stroke Discussion Young age, male, high DBP, less hypertension, less anemia, lower initial NIHSS score Similar favorable baseline data as previous studies Favorable baseline characteristics in smokers may play an important role in prognosis. Minor risk factor True prognostic effect of smoking may appear after adjusting baseline difference. The occurrence of stroke is 5 years earlier in smoker than that in nonsmokers. Prognostic influence Smokers have less severe neurological deficit on admission than did nonsmokers in acute stroke. Smoking is not independently associated with initial severity and interval change of neurological deficit in this study. Short-term outcome may reveal the true appearance of prognosis. Increased confounders in study of long-term prognosis Effect of cessation of smoking Effect of change in other risk profiles Effect of other co-morbidity First-ever and recurrent stroke We hypothesized that smoker with recurrent stroke will show poor outcome due to smoking. There was no significant difference in either first-ever or recurrent stroke. Maybe too minor to show the effect if patients have multiple major risk factors

Limitations Patient data lack of admission or discharge record were excluded in the analysis. Sugar is not considered as a variable Onset timing is not well defined. Ex-smoker and pack-year are not differentiated. Conclusions The occurrence of stroke is 5 years earlier in smoker than that in nonsmokers despite relatively good risk profiles. Smoking is not significantly associated with initial severity and interval change of neurological deficit. Prognostic effect of smoking in stroke is relatively minor when comparing with the contribution to occurrence. True prognostic influence of smoking may appear after adjusting confounders adequately. Prospective study is needed to clarify the uneven results in the further. Thanks for your attention!! Coronary artery disease (CAD) MI is increased sixfold in women and threefold in men who smoke at least 20 cigarettes per day Cigarette smoking increases all-cause and cardiovascular mortality. Patients who continue to smoke in the presence of CAD have an increased risk of reinfarction and an increased risk of death, including sudden cardiac death. Smoker's Paradox Despite the role of smoking in atherosclerosis, several studies have reported that smokers who receive a fibrinolytic agent for an acute MI have a better outcome than nonsmokers.

Prognostic influence Smoking predicts long-term mortality in stroke Preventive Medicine 42 (2006) 128 131 Smoker's Paradox Despite the role of smoking in atherosclerosis, several studies have reported that smokers who receive a fibrinolytic agent for an acute MI have a better outcome than nonsmokers. How about cerebral infarction? Recurrent stroke Improved outcome after atherosclerotic stroke in male smoker, Journal of the Neurological Sciences 260 (2007) 43 48 Nonsmokers (n=565) Smokers (n=247) p value Status upon discharge NIHSS 7.1±8.9 4.9±6.1 <0.001 BI 61.5±35.2 70.2±32.7 0.001 mrs 3.3±1.8 2.8±1.9 0.001 Neurological change ΔNIHSS 0.4±5.6 0.8±4.6 0.241 Functional change ΔBI 8.5±22.8 7.9±22.0 0.7 ΔmRS 0.4±1.5 0.5±1.5 0.548 Pneumonia 48(8.5%) 13(5.3%) 0.108 Acute ward stay (days) 10.3±6.6 10.1±6.8 0.602 The smoking thrombolysis paradox and acute ischemic stroke, Neurology 2005;65:293 295